Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 22.22
(0.63%)
CNY 22.22
(0.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.17 Billion CNY | 11.14% |
| 2022 | 2.85 Billion CNY | 45.54% |
| 2021 | 1.96 Billion CNY | 15.47% |
| 2020 | 1.69 Billion CNY | 26.76% |
| 2019 | 1.34 Billion CNY | 12.53% |
| 2018 | 1.19 Billion CNY | 28.63% |
| 2017 | 926.34 Million CNY | 51.34% |
| 2016 | 612.09 Million CNY | 1.02% |
| 2015 | 605.9 Million CNY | 20.94% |
| 2014 | 500.99 Million CNY | 22.39% |
| 2013 | 409.35 Million CNY | 49.4% |
| 2012 | 274 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.1 Billion CNY | -3.68% |
| 2024 Q3 | 3.05 Billion CNY | -1.68% |
| 2024 Q1 | 3.22 Billion CNY | 1.61% |
| 2023 Q2 | 3.02 Billion CNY | 1.4% |
| 2023 Q1 | 2.98 Billion CNY | 4.5% |
| 2023 FY | 3.17 Billion CNY | 11.14% |
| 2023 Q4 | 3.17 Billion CNY | 6.62% |
| 2023 Q3 | 2.97 Billion CNY | -1.63% |
| 2022 Q1 | 2.03 Billion CNY | 3.6% |
| 2022 FY | 2.85 Billion CNY | 45.54% |
| 2022 Q4 | 2.85 Billion CNY | 27.83% |
| 2022 Q3 | 2.23 Billion CNY | 9.16% |
| 2022 Q2 | 2.04 Billion CNY | 0.68% |
| 2021 Q4 | 1.96 Billion CNY | 7.6% |
| 2021 Q2 | 1.8 Billion CNY | 0.06% |
| 2021 Q3 | 1.82 Billion CNY | 0.82% |
| 2021 Q1 | 1.8 Billion CNY | 6.37% |
| 2021 FY | 1.96 Billion CNY | 15.47% |
| 2020 Q4 | 1.69 Billion CNY | -3.74% |
| 2020 Q1 | 1.38 Billion CNY | 3.53% |
| 2020 Q2 | 1.7 Billion CNY | 22.86% |
| 2020 FY | 1.69 Billion CNY | 26.76% |
| 2020 Q3 | 1.76 Billion CNY | 3.54% |
| 2019 Q1 | 1.24 Billion CNY | 4.76% |
| 2019 Q2 | 1.22 Billion CNY | -1.6% |
| 2019 Q3 | 1.23 Billion CNY | 0.93% |
| 2019 FY | 1.34 Billion CNY | 12.53% |
| 2019 Q4 | 1.34 Billion CNY | 8.16% |
| 2018 Q2 | 1.1 Billion CNY | 12.14% |
| 2018 FY | 1.19 Billion CNY | 28.63% |
| 2018 Q4 | 1.19 Billion CNY | 9.89% |
| 2018 Q1 | 987.54 Million CNY | 6.61% |
| 2018 Q3 | 1.08 Billion CNY | -2.09% |
| 2017 Q2 | 886.96 Million CNY | 46.96% |
| 2017 Q3 | 883.62 Million CNY | -0.38% |
| 2017 Q4 | 926.34 Million CNY | 4.83% |
| 2017 FY | 926.34 Million CNY | 51.34% |
| 2017 Q1 | 603.55 Million CNY | -1.39% |
| 2016 Q4 | 612.09 Million CNY | 0.0% |
| 2016 Q2 | 609.31 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 612.09 Million CNY | 1.02% |
| 2015 FY | 605.9 Million CNY | 20.94% |
| 2014 FY | 500.99 Million CNY | 22.39% |
| 2013 FY | 409.35 Million CNY | 49.4% |
| 2012 FY | 274 Million CNY | 0.0% |